Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
VG Life Sciences logo — Developing lifesaving therapies for drug-resistant cancers a...

VG Life Sciences

Developing lifesaving therapies for drug-resistant cancers and autoimmune diseases through innovative research and advanced drug technologies.

Founded 1995 Post Ipo Equity Total: $2.79M Biotechnology, Health Care

General Information

Company Name VG Life Sciences
Founded Year 1995
Industries Biotechnology, Health Care
Funding Stage Post Ipo Equity
Social

Get notified when VG Life Sciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About VG Life Sciences

VG Life Sciences is a biotechnology startup dedicated to developing innovative therapies for drug-resistant cancers and autoimmune diseases. The company's focus on advancing research and development is facilitated by two platform technologies: Targeted Peptide Technology (TPT) and Metabolic Disruption Technology (MDT). The company's flagship drug, VG1177, has shown promising potential, holding a composition-of-matter patent (Patent No: US 8,957,031). VG1177 aims to inhibit the survival of pro-inflammatory cells responsible for autoimmune diseases. Having completed a pre-investigational new drug meeting with the FDA (IND # 110820) and initiated preclinical work in November 2013, VG Life Sciences is making significant strides towards clinical trials. Concurrently, the company is conducting extensive research at the Texas A&M Health Sciences Center laboratory, collaborating with research scientists from various institutions nationwide. In 2013, the company secured a $2.24M Post-IPO Equity investment from MedBridge Venture Fund, underscoring the investor confidence in VG Life Sciences' groundbreaking approach to addressing critical medical challenges. Founded in 1995, VG Life Sciences continues to drive forward in the biotechnology and healthcare industries, poised to make a profound impact with its pioneering drug technologies.

Taxonomy: pharmaceuticals, drug development, cancer treatment, autoimmune diseases, therapeutic research, patent technology, clinical trials, preclinical studies, FDA approval, metabolic disruption, peptide technology, innovative therapies, medical innovation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 1 •••• •••• 02 Oct 2013
Post-IPO Equity •••••• - 01 Mar 2013

VG Life Sciences Alternatives & Competitors

VG Life Sciences vs
Vastu Vihar Biotech Pvt. Ltd.
Vastu Vihar Biotech Pvt. Ltd. India

Research and product development

75 employees
Agriculture, Biotechnology
VG Life Sciences vs
ProPharma
ProPharma United States

End-to-end bespoke solutions that de-risk & accelerate our partners' and sponsors' drug and device d...

2246 employees
VG Life Sciences vs
BioSymetrics (a Lunai Bioworks company)
BioSymetrics (a Lunai Bioworks company) United States

Phenomics-driven. Remote-first. This is the future of drug discovery.

Seed
13 employees
AI, Analytics

FAQ About VG Life Sciences

Developing lifesaving therapies for drug-resistant cancers and autoimmune diseases through innovative research and advanced drug technologies.
VG Life Sciences was founded in 1995.
VG Life Sciences operates in the following industries: Biotechnology, Health Care.
VG Life Sciences has completed 2 funding rounds, raising a total of $2.79M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to VG Life Sciences include Vastu Vihar Biotech Pvt. Ltd., ProPharma, BioSymetrics (a Lunai Bioworks company), Azadyne, MediSieve. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VG Life Sciences and Vastu Vihar Biotech Pvt. Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors VG Life Sciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes